We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

IsoPlexis Proteomic Product Suite for Neuroinflammation

Learn how IsoPlexis’ Functional Proteomics reveals unique secretomic signatures and insights into neuroinflammation.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Understanding the mechanism of disease progression in neuroInflammation
The neural impact of T cells and inflammatory cytokines in Alzheimer’s disease
The role of innate immunity in Multiple Sclerosis (MS) pathogenesis
Revealing biomarkers of neurotoxicity and Immune Related Adverse Events (IRAEs)
Neurological manifestations of COVID-19 in patients
Informing targeted combination therapy to overcome resistance in Glioblastoma (GBM) with single-cell intracellular proteomics
A Deeper Look

More about this

Overcoming Challenges in Neuroinflammation

Neuroinflammation is a complex biological response to nervous tissue injury involving many inflammatory mediators, such as cytokines, chemokines, and many different cell types.

Heterogeneity in cytokine production and aberrant cytokine signatures can create challenges in assessing neuroinflammation.

Download this App Note to learn how IsoPlexis helps you overcome these challenges by functionally defining each cell type to inform more effective therapies.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the